# Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations

> **NCT00272753** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 20 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** budesonide/formoterol Turbuhaler
- **DRUG:** formoterol Turbuhaler
- **DRUG:** salbutamol

## Key facts

- **NCT ID:** NCT00272753
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 20 (—)
- **Last updated:** 2011-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272753, "Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00272753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*